MONTEGO BAY, Jamaica, May 12, 2021 (GLOBE NEWSWIRE) — Silo Wellness Inc. (“Silo Wellness” or “the Company”) (CSE: SILO) (FRA: 3K70), a leading global psychedelics company has today announced it will expand its portfolio of psilocybin and ketamine product and retreat offerings to also include 5-MeO-DMT through a partnership with Kaivalya Kollectiv, an L.A.-based wellness company that conducts…


Previous articleExploring Oregon’s Measure 110 and The Future of Drug Policy Reform
Next articleMindMed Bolsters Management Team, Appoints Peter Mack PhD as Vice President of Pharmaceutical Development